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Diet, vitamin D and vertebral mineral density in hypercalciuric calcium
stone formers. To elucidate the pathophysiology of dietary calcium
independent hypercalciuria, 42 calcium stone formers (Ca SF) were
selected because they had on free diet a calciuria greater than 0. 1
mmol/kg/day. For four days they were put on a diet restricted in
calcium (Ca RD) by exclusion of the dairy products. They collected 24
hour urines on free diet and on day 4 of Ca RD as well as the two-hour
fasting urines on the morning of the day 5 and the four-hour urines
passed after an oral calcium load of 1 g, for measurement of creatinine,
Ca, P04, urea and total hydroxyprolinuria (THP). On day 5 fasting
plasma concentrations of Ca, P04, intact PTH, Gla protein, calcidiol
and calcitriol were measured. The patients were firstly classified into
dietary hypercalciuria (DH, 18 patients) and dietary calcium-indepen-
dent hypercalciuria (IH, 24 patients) on the basis of the disappearance
or not of hypercalciuria on Ca RD. Then the patients with IH were
subclassified into absorptive hypercalciuria (AH) because of normal
fasting calciuria (8 patients) and into fasting hypercalciuria (16 patients).
Fasting hypercalciuric patients were subsequently divided according to
the PTH levels into renal hypercalciuria (RH, 1 patient) with elevated
fasting PTH becoming normal after the Ca load and undetermined
hypercalciuria (UH, 15 patients) with normal PTH levels. Furthermore,
their vertebral mineral density (VMD) was measured by quantitative
computerized tomography which was normal in DH (91 6% of the
normal mean for age and sex) but was decreased in lH to 69 4%. No
difference in VMD was observed between AH and UH. Urinary
excretions of urea, phosphate and THP was higher in IH than in DH and
comparable in AH and UH. Sodium excretion Ca RD was the same in
all groups and subgroups as well as the plasma parameters. Plasma
calcitriol was increased in IH and DH comparatively to normal in spite
of normal plasma calcidiol. Calciuria increase after oral calcium load,
an index of Ca absorption, was higher in IH than in controls and
comparable in IH and DH as well as in the three subgroups of IH. From
these data and correlation studies in IH it is concluded: (1.) VMD is
decreased in Ca stone formers with IH but not in those with DH,
making the distinction of these two groups of hypercalciuria patients
clinically relevant. (2.) The further distinction within IH of AH, RH and
UH is not very justified, since RH is exceptional and VMD and other
biochemical parameters (with the exception of those taken for subclas-
sification) are not different between AH and UH. (3.) Since in lH,
fasting hydroxyprolinuria and fasting calciuria were greater than in
control, whereas plasma PTH concentrations were low to normal (with
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the exception of the case with RH), and fasting calciuria was correlated
to fasting hydroxyprolinuria, it is suggested that a primary bone
hyperresorption, and not a primary renal leak of calcium or a primary
intestinal hyperabsorption, is the main cause of IH. (4.) IH is associated
with higher urea excretion on free and Ca R diets than in controls,
suggesting a higher protein intake of no dairy origin. This higher intake
may favor bone resorption since fasting calciuria and hydroxyprolinuria
are correlated to urea excretion. (5.) In IH, the positive correlations of
calcitriol with VMD and calciuria increase after Ca oral load, and the
negative one between calcitriol and fasting calciuria, suggest that
calcitriol attenuates bone resorption by increasing calcium absorption.
(6.) In lH, plasma calcitriol is correlated positively to calcidiol and
negatively to plasma phosphate which remains in the normal range.
Therefore, increased plasma calcitriol in IH may be explained by a
hypersensitivity of 25 (OH) vitamin D1, hydroxylase to PPO4, making
its synthesis dependent upon 25 (OH) D. (7.) Exclusion of dairy
products might be deleterious for the skeleton in Ca stone formers.
Restriction of protein intake of non-dairy origin should rather be
advised.
Idiopathic calcium stone disease is a multifactorial disease
and hypercalciuria, present in 30 to 60% of the patients, is its
most frequent risk factor [1]. Hypercalciuria due to an exces-
sive intake of calcium is called absorptive hypercalciuria type II
or dietary hypercalciuria [2]. When hypercalciuria persists in
spite of normal or restricted calcium intake it is usually called
idiopathic hypercalciuria. The pathogenesis of this disorder is
still highly controversial. Pak et al [2] classify idiopathic hyper-
calciuria into three distinct pathogenetic subtypes according to
three independent, primary metabolic defects: (1) absorptive
hypercalciuria type I when a primary intestinal hyperabsorption
of calcium is involved; (2) absorptive hypercalciuria type III
when a primary renal leak of phosphate is present inducing
hypophosphatemia, and secondarily calcitriol-mediated intesti-
nal hyperabsorption of calcium; (3) renal hypercalciuria when a
primary renal leak of calcium is present inducing secondary
hyperparathyroidism with calcitriol mediated hyperabsorption
of calcium. According to Pak, "resorptive hypercalciuria," that
is, a hypercalciuria due to primary bone hyperresorption, is
always in relation to a nosologically well defined bone disease
like primary hyperparathyroidism, Cushing's syndrome or hy-
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perthyroidism, the presence of which excludes the diagnosis of
idiopathic hypercalciuria. Other authors do not agree, however,
with such a clear-cut metabolic classification for various rea-
sons:
(a) This classification does not take into account the depen-
dence of idiopathic hypercalciuria on dietary factors other than
the calcium intake, especially the intakes of sodium and pro-
tein, which now appear to be well established [3—5].
(b) The overprevalence of the absorptive hypercalciuria type
I of Pak et al's definition (2/3 of the patients with idiopathic
hypercalciuria) is in blatant contradiction with calcium balance
data which show a negative balance in 2/3 of the patients U, 61
[the average calcium balance for the hypercalciuric calcium-
stone formers is —1.0 2.7 mmol!day (—40 108 mg/day),
whereas it is +0.7 2.4 mmollday (28 96 mg/day) in healthy
controls] [1].
(c) Primary disorders of the intestinal calcium absorption and
tubular reabsorption of calcium or phosphate appear to be
variously associated in the same patients, making their classi-
fication into distinct pathogenetic subtypes not always possible
[5—71.
(d) The classification of Pak et al is not able to classify all
patients, namely those with fasting hypercalciuria not related to
a high sodium intake. Most of these patients don't have high
plasma concentrations of PTH, but normal or low concentra-
tions, which excludes the hypothesis of a renal hypercalciuria
[81. Since in these patients total hydroxyprolinuria is increased,
a primary bone resorption not related to a defined nosological
entity has been advocated [9].
To clarify the pathogenesis of idiopathic hypercalciuria, we
selected 42 calcium stone formers with hypercalciuria on free
diet. These patients were investigated by measuring their ver-
tebral mineral density simultaneously with their urinary excre-
tion of calcium, phosphate, sodium, urea and total hydroxypro-
line on free and calcium restricted diets and in fasting condition
in order to assess the relationship of their calcium excretion
with sodium and protein intake and bone catabolism. Plasma
parameters of the mineral metabolism were measured to get
some insight into the hormonal control of this metabolism.
Methods
Design of the biochemical evaluation of the patients
Forty-two calcium stone formers with normal renal function
were selected because on free diet they had a calciuria higher
than 4 mg/kg/day (>0.1 mmol/kg/day), normocalcemia, and no
other clinical or biological evidence for sarcoidosis, lymphoma
or complete distal renal tubular acidosis (normal plasma bicar-
bonate and potassium, fasting urinary pH 6.3). Review of
their excretory urOgram disclosed, however, three patients with
an unequivocal pattern of medullary sponge kidney (MSK)
according to the criteria given by Parks, Coe and Strauss [10],
namely radial linear striations or cystic collections of contrast
medium in the absence of concurrent obstruction of either
kidney observed at least in half the papillae of both kidneys. For
four days the 42 patients were put on a calcium restricted diet of
about 400 mg by exclusion of all dairy products, while moderate
sodium intake (no salt on the table) and exclusion of food rich
in gelatine was prescribed. They were asked to collect their 24
hour urine on day 4 of this diet, as well as a fasting two-hour
urine (7:00 to 9:00 a.m.) on the morning of day 5 after 12 hours
of fasting. At 9 a.m. of this day they had their blood drawn and
they were given an oral load of 1 g of elemental calcium (as
gluconolactate and carbonate in 2 tablets of Calcium Forte
Sandoz). Their urine was collected during the four following
hours, and their blood was drawn again at 1 p.m.
Biochemical measurements
Plasma concentrations of the following parameters were
measured: creatinine, calcium, phosphate, bicarbonate, pro-
tein, alkaline phosphatase by autoanalyzer techniques.
Bone Gla protein by radioimmunoassay with the CIS inter-
national kit was measured according to the method developed
by Delmas et al [111.
Calcidiol was measured by a radio-competition assay [121 and
calcitriol by a radioimmunoassay described by one of us [13].
Intact PTH by radioimmunoassay using the Nichols Institute
kit according to the method developed by Kao et a! was
determined in serum samples [14].
In the 24-hour urine collected on free and calcium restricted
diet, the following parameters were measured: creatinine, cal-
cium, phosphate, urea, total hydroxyproline (THP) (the latter
only on calcium restricted diet) by an autoanalyzer [15] On the
fasting urines, creatinine, calcium and THP were measured. On
the four hour urine following the calcium load, calcium and
creatinine were measured again. All the urinary excretions have
been reported by mmol of creatininuria to eliminate the urine
sampling error.
Control values of the biochemical data
Control data for biochemical parameters were derived from
different control populations but always explored in the same
dietary conditions as the patients.
Normal values for calcium, phosphate, sodium and urea
excretions as well as for plasma calcium, phosphate and protein
were obtained in 41 healthy men and 21 healthy women in
whom urolithiasis was excluded by X-rays and who had no
clinical disorder affecting the calcium phosphate metabolism.
Control values for hydroxyprolinuria were obtained in 22
other healthy subjects studied after four days of Ca R diet and
in fasting conditions. These controls were 15 men and 7 women
with a mean age of 35 years.
Control values for serum PTH, plasma 25 (OH) vitamin D,
plasmal,25 (OH)2 vitamin D3 were obtained in 12 controls (7
males, 5 females) without history of stone disease or distur-
bance of calcium metabolism. These control individuals had the
same dietary conditions as the patients, namely, four days of Ca
restricted diet with low gelatin intake. At odds with the pa-
tients, plasma samples of these controls were taken mainly in
March for 10 of them, whereas they were taken throughout the
year for the patients (5 times in summer, 4 times in autumn, 4
times in spring, 4 times in winter for the patients with dietary
hypercalciuria and 10 times in summer, 5 times in autumn, 5
times in winter and 4 times in spring for the patients with
idiopathic hypercalciuria).
Classification of the patients
Based on our own control data of calcium excretion on
various diets and of fasting serum PTH concentrations, the
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Table .1. Urine biochemical parameters according to the calcium diet
Calcium diet
N
Urinary
parameter
per mmolLJ.
Dietary
Controls hypercalciuria
61 18
Dietary
calcium-
independent
hypercalciuria
24
Dietary calcium
-independent hypercalciuria
Absorptive
hypercalciuria
type I
8
Renal
hyper-
calciuria
1
Undetermined
hyper-
calciuria
15
Free Ucammol
U04mmol
Uurammol
UNammol
0.33 0.02 0.55 0.04'
1.9 0.08 2.1 0.1
26 1 23 1
10 0.4 12 la"
0.74 004b3,c3
2.3 0.22
27
12 ll3
0.62 0.04
2.1 0.1
25 1
13 1
0.86
1.74
22
11
0.79 0.06
2.5 0.2
28 I
12 1
10 mmol/day Ucammol
U4mmol
Uureammol
UNammol
UTHPmol
0.21 0.01 0.31 0.02
1.8 0.05 1.9 0.1
23 1 24 1
9 0.5 9 1
21 ie 24 2
0.62 004b3.c3
2.3 O.2I2c228 i"
10 232 2''
0.47 0.03
2.0 0.126 212 2
27 5
0.83
2.5
23
9
31
0.67 004d3
2.4 0.2
29 2
10 1
34 3
Fasting UcammOl
U04mmol
UTHPmol
0.16 0.01 0.22 0.02
1.6 0.2 1.6 0.1
21 1 24 2
0.44 0.053c3
1.6 1.2
29
0.22 0.03
1.8 0.524 3
0.66
2.4
31
0.55 006d3
1.4 2
31 4
After 25 mmol
Ca load
Ucammol
Ucammo1
0.51 0.03 0.67 0.09
0.37 0.030.47± 0.07
0.99 0.05l3
0.55 0•05b3
0.79 0.06
0.57 006b1
1.11
0.45
1.08 0.07I2
0.53 008b1
Significance of the comparisons:
Controls versus dietary hypercalciuria: a! P < 0.05; a2 p < a3 P < 0.01
Controls versus idiopathic hypercalciuria: b! p < 0.05; h2 P < 0.02; b3 p < 0.01
Dietary versus idiopathic hypercalciuria: P < 0.05; c2 P < 0.02; c3 P < 0.01
Absorptive I versus undetermined hypercalciuria: dl p < 005W d2 P < 0.02; d3 P < 0.01
These controls were only 15 males and 7 females. Data are presented as means SE.
patients were classified according to Pak et al [2] into the
following groups:
Dietary hypercalciuria (DH). (This correlated with absorp-
tive hypercalciuria type II of Pak et al.) When their calciuria on
a calcium restricted diet was below the upper limit of our
controls, that is, 0.07 mmol/kg/day (<2.8 mg/kg/day), 18 pa-
tients could be included in this group.
Dietary calcium-independent hypercalciuria (IH). This was
defined as patients who had calciuria still above 0.07 mmol/kg/
day in spite of the calcium restricted diet. Actually this type of
hypercalciuria was called "idiopathic" by Pak et a! [2] and Coe
and Bushinsky [6], even though these authors did not eliminate
the patients with medullary sponge kidney (Discussion). Patients
with IH were subsequently classified into: (1) absorptive hyper-
calciuria type I when fasting calciuria was lower than 0.33
mmoLlmmol urinary creatinine (the upper limit of our controls)
(N = 8 patients); (2) renal hypercalciuria when fasting calciuria
was greater than 0.33 mmol/mmol urinary creatinine, whereas
fasting PTH was elevated but decreased to normal after the
calcium load; these criteria were fulfilled in only one patient
with MSK. (3) The remaining 15 patients with fasting hypercal-
ciuria and normal plasma PTH were classified in the undeter-
mined hypercalciuria subgroup.
The number of previously formed Ca stones is in Table 3.
Measurement of vertebral mineral density
Vertebral mineral density (VMD) was determined using
quantitative computerized tomodensitometry (CT). The mea-
surement was performed in the third lumbar vertebra and used
a calibration phantom [16, 17]. The calibration phantom is made
of five tubes filled with progressively titrated solutions of K2
HPO4. The regression line of the calibration test allows conver-
sion between Hounsfield units and equivalent values of K2
HPO4 expressed in mg/ml of spongious bone. The normal
regression line of VMD related to age was determined for each
sex in a group of 239 controls (106 males, 133 females). This
regression line permits the results of our patients to be ex-
pressed in percent of the normal mean for age and sex.
Statistical analyses
Student's t-test and the non-parametric test of Wilcoxon for
unpaired data were used to compare each parameter between
the different groups and subgroups. The results are given as
mean SEM.
In each group, linear correlations between various parame-
ters were calculated by the least-squares method. When a
significant correlation was observed, Spearman's rank correla-
tion coefficient was determined to verify that the correlation
was not skewed by extreme values.
Results
Urinary parameters
Calcium excretion. The 24 hour excretions of calcium were
by selection in accordance with the criteria taken for the
classification of the patients, that is, on free diet, higher in the
two hypercalciuric groups than in controls; on calcium re-
stricted diet, higher in the group with dietary calcium-indepen-
dent hypercalciuna (IH) than in controls and in DII (Table 1).
Calciuria. In the IH group, fasting calciuria was higher than
in controls and dietary hypercalciuria. By definition, fasting
calciuria was normal in absorptive hypercalciuria type I (8
patients) and increased in the single patient with renal hyper-
calciuria. Fasting calciuria was increased in the group with
undetermined hypercalciuria. This group of 15 patients repre-
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Table 2. Fasting plasma phosphocalcic parameters
Dietary Idiopathic
Idiopathic hypercalciuria
Absorptive Renal Undetermined
Controls 61 hypercalciuria hypercalciuria hypercalciuria I hypercalciuria hypercalciuria
Plasma concentrations N (12) 18 24 8 1 15
Calcium mmoi/iiter 2.40 0.03 2.36 0.02 2.38 0,02 2.35 0.04 2.35 2.37 0.03
Phosphate mmoi/liter 1,00 0.03 1.01 0.06 0.97 0.02 0.91 0.03 0.98 1.00 0.03
Intact PTH pg/mi 38 4 32 4 32 3 31 5 74/42 28 4
Gla protein pg/mi 6 1 9 1 8 1 9 1 12 8 1
AlkalinelUphosphatase 135 5 104 7 101 7 104 11 102 99 9
Calcidiol ng/ml 12 1 14 2 14 1 14 3 6 12 1
Calcitriol pg/mi 50 4 69 5' 69 5C 75 6 58 67 7
Data are presented as means SEM. The second figure of PTH for the patient with renal hypercalciuria is that measured 4 hours after the calcium
load.
Significance of the comparisons:
Controls versus dietary hypercalciuna: a P < 0.02
Controls versus idiopathic hypercalciuria: ' P < 0.02
sented the most important subtype of IH (60%), which explains
why the whole group of IH had increased fasting calciuria.
After oral calcium load, calciuria in the IH group was
significantly higher than in controls. This was due mainly to the
subgroup with undetermined hypercalciuria which had a post
calcium load calciuria greater than that of the group with
absorptive hypercalciuria I. The increase of calciuria Ua)
induced by the Ca load was also significantly higher in the IH
group than in controls. It was comparable in dietary and
idiopathic hypercalciuria as well as in the various subgroups of
idiopathic hypercalciuria.
The urinary phosphate excretion on free diet was significantly
higher in IH than in controls. No difference was observed
between the two groups of hypercalciuric patients and between
the three subgroups of IH. On Ca restricted diet, phosphaturia
was greater in IH than in controls and in dietary hypercalciuria.
No significant difference was observed between the three
subtypes of dietary calcium-independent hypercalciuria. Fast-
ing urinary phosphate was comparable in the 2 groups and in the
controls.
Sodium excretion. The urinary excretion of sodium in the
patients with DH and IH on free diet was higher than in
controls. Sodium excretion was not different between the three
subtypes of idiopathic hypercalciuria. On Ca restricted diet,
that is, the day before the measurement of the fasting calciuria,
no significant difference was observed in the sodium excretion
between each group of patients and the controls, nor between
the three subtypes of dietary calcium-independent hypercalci-
uria. This was true whether the sodium excretion was ex-
pressed per mmol of creatinine or as the absolute daily excre-
tion (mean SEM for controls: 130 11; DH: 148 17; IH: 162
18 mmol/24 hr; differences not significant). In the subgroups
of IH mean SEM of natriuresis per 24 hours was 186 37 for
the absorptive hypercalciuria type 1, 156 20 for the undeter-
mined hypercalciuria and 68 mmol for the renal hypercalciuric
patients. The differences were not significant.
Total urea. The urinary excretion of urea on free and Ca
restricted diets in patients with DH was comparable to that of
controls and significantly lower than in patients with IH. No
difference in urea excretion was observed between the three
subtypes of IH.
THP. Total hydroxyprolinuria (THP) on Ca restricted diet
was higher in patients with IH than in controls and in patients
with DH. Fasting THP in the patients with IH was also higher
than in controls but not higher than in patients with DH. No
significant difference in THP was observed between the 3
subtypes of IH.
Plasma parameters
There was no significant difference between each group of
patients and the controls as regards the plasma concentrations
of calcium, phosphate, intact PTH, alkaline phosphatase, Gla-
protein and calcidiol, nor the serum PTH concentrations (Table
2). Plasma calcitriol was significantly higher in the patients with
DH and IH than in the controls. No significant difference was
observed for all the plasma parameters between absorptive
hypercalciuria type I and undetermined hypercalciuria. By
definition, the only patient with renal hypercalciuria had ele-
vated serum PTH which decreased to normal after the calcium
load.
Clinical and vertebral mineral density data
Whereas there was no difference as regards the sex ratio and
body weight between the various groups and subgroups of Ca
stone formers (Table 3), the vertebral mineral density (VMD)
was significantly lower in patients with IH (69 4%) than in
patients with DH (91 6%) or in controls (100%). No signifi-
cant difference in VMD was observed between the patients with
undetermined hypercalciuria and those with absorptive hyper-
calciuria I. The single patient with renal hypercalciuria had a
remarkable low VMD of 54%. Two other patients with fasting
hypercalciuria of 0.34 and 0.68 mmollmmol Uc had still lower
VMD values at 50 and 35%.
Correlation studies
Table 4 summarizes only the significant correlations observed
in the controls and in the two groups of hypercalciuric patients.
Controls. In the controls fasting calciuria was correlated to
urea excretion on free diet (Ua/Ur = 0.009 + 0.005 Uurea/
but not on low calcium diet (Ua/Ur 0.057 + 0.004
Uurea/Ucr). On free diets but not on low calcium diets, urea and
phosphate excretions were correlated. No inverse correlation
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Table 3. Clinical data and vertebral mineral density
Idiopathic hypercalciuria
Dietary Idiopathic Absorptive Renal Undetermined
Parameters Controls hypercalciuria hypercalciuria hypercalciuria hypercalciuria hypercalciuria
N 61 18 24 8 1 15
Sex ratio FIM 20/41 6/12 7/17 1/7 0/1 6/9
Ageyears 35±5 42±5 45±4 41±3 56 49±3
Body weight kg 70 1.7 74 3.5 71 3 69 4 63 72 4
Prior calcium stone 2.5 0.25 3.23 0.5
occurrence
Vertebral mineral 100 10 91 6 69 4C 71 4 54 68 5
density % of
normal mean
Data are presented as means SEM. The number of the controls for vertebral mineral density as 239 (106 males, 133 females).
Significance of the comparisons:
Controls versus dietary hypercalciuria: a none is significant
Controls versus idiopathic hypercalciuria: b P < 0.01
Dietary versus idiopathic hypercalciuria: P < 0.01
Absorptive I versus undetermined hypercalciuria: d none is significant
Table 4. Significant correlation in the controls, dietary and idiopathic hypercalciuria
Least-squares
—
Spearman
Group First parameter Second parameter N r P r P
Controls Uurea(free diet) Uc(fasting) 44 0.44 <0.01 0.41 <0.01
Uura(400 mg) U(fasting) 44 0.26 <0.10 0.2 NS
Uura(free diet) U4(free diet) 44 0.40 <0.01 0.4 <0.01
Uur,a(400 mg) U4(400 mg) 44 0.25 <0.05 0.18 NS
Plasma calcitriol Plasma calcidiol 12 0.74 <0.01 0.70 <0.01
Dietary Uurea(free diet) U04(free diet) 18 0.55 <0.03 0.52 <0.05
hypercalciuria Uurea(400 mg) U04(400 mg) 18 0.62 <0.01 0.73 <0.01
Idiopathic Uca(free diet) Uurea(free diet) 23 0.50 <0.01 0.47 <0.02
hypercalciuria U0 (free diet) Uura(free diet) 23 0.50 <0.01 0.7 <0.01
Uca(400 mg) Uurea(400 mg) 23 0.58 <0.01 0.48 <0.02
U04(400 mg) Uurea(400 mg) 23 0.40 =0.05 0.46 =0.02
UTHP(400 mg) Uurea(free diet) 16 0.67 <0.01 0.49 <0.05
UTHP(400 mg) Uurea(400 mg) 16 0.49 <0.05 0.49 <0.05
U(fasting) Uura(400 mg) 15 0.50 <0.05 0.54 <0.05
Uc(fasting) UT(fasting) 15 0.69 <0.01 0.48 =0.05
Uca(fasting) Uurea(400 mg) 23 0.61 <0.01 0.41 <0.05
Uca(fasting) Uura(free diet) 23 0.58 <0.01 0.4 =0.05
U(fasting) VMD L3 23 —0.28 =0.10 —0.37 =0.07
Plasma calcitriol VMD L3 23 0.50 <0.01 0.44 <0.05
Plasma calcitriol Fasting Ua 23 —0.41 <0.05 —0.45 <0.05
Plasma calcitriol U(load) 23 0.65 <0.01 0.57 <0.01
Plasma calcitriol Plasma calcidiol 21 0.65 <0.01 0.56 <0.01
Plasma calcitriol Plasma P04 22 —0.5 <0.01 —0.61 <0.01
Plasma PTH Plasma Gla protein 20 0.63 <0.01 0.24 NS
—
Plasma PTH U4fasting 23 0.46 <0.01 0.61 <0.01
Abbreviation is: VMD L3, vertebral mineral density of L3.
a The 2 patients with hypophosphatemia have been excluded
was found in healthy controls between fasting plasma phos-
phate and plasma calcitriol concentrations. A positive correla-
tion between plasma calcidiol and plasma calcitriol has been
found in this group of controls. Vertebral mineral density was
not correlated with any biochemical parameters.
Hypercalciuria. In patients with dietary hypercalciuria, urea
and phosphate excretions were correlated on both diets. No
correlations was found in this group between plasma calcitriol
and plasma or serum concentrations of phosphate, calcium,
calcidiol, PTH and Gla protein. Vertebral mineral density was
not correlated with any of the biochemical parameters.
In patients with dietary calcium independent hypercalciuria
(IH), calcium and phosphate excretions were correlated with
urea excretion on both diets. Hydroxyprolinuria on calcium
restricted diet was correlated with urea excretion on both free
and calcium restricted diets. Fasting hydroxyprolinuria was
correlated to urea excretion on Ca restricted diet (2.1 + 0.93
Uurea; Fig. 1). Fasting calciuria was correlated to fasting
hydroxyprolinuria (Fig. 2) as well as to urea excretion on free
and calcium restricted diets. The slope of the regression line
between fasting calciuria and urea excretion on free diet was
five times steeper in IH than in the controls (0.024 vs. 0.005,
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Fig. 2. Correlation of fasting calciuria and fasting total hydroxyproli-
nuria in patients with dietary calcium-independent hypercalciuria. y =
0.06 + 0,015x; r = 0.69; P < 0,01.
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Fig. 1. Correlation of fasting total hydroxyprolinuria with urea excre-
tion on calcium restricted diet in patients with dietary calcium-indepen-
dent hypercalciuria. y = 2.1 + 0.93x; r = 0.50; P < 0.05.
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Fig. 3. Comparison of the slopes of the regression line of fasting
calciuria versus urea excretion on free diet in controls (•, 0.005) and in
patients with dietary calcium-independent hypercalciuria (0, 0.024).
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Fig. 4. Correlation of vertebral mineral density with fasting plasma
calcitriol in patients with dietary calcium-independent hypercalciuria. y
39 + 0,44x; r 0.50; P < 0.01.
was also positively correlated to plasma caicidiol (Fig. 7) and
negatively to plasma phosphate. The correlation between
plasma P04 and plasma caicitriol has been confirmed after
exclusion of two patients who had hypophosphatemia (patient
1, plasma P04 = 0.64 mmol/liter, plasma calcitriol = 101 pg/mI;
patient 2, plasma P04 = 0.74 mmollliter, plasma calcitriol = 115
pg/mi), The new correlation determined with 22 paired data is
still significant (P < 0.02, r = 0.5, least squares method; P <
0.01, r = 0.61, Spearman's rank correlation coefficient; Fig. 8).
To exclude the role of decreased plasma calcidiol values in
the correlation observed in IH between plasma calcidiol and
plasma calcitriol, the correlation was again determined after
exclusion of six patients with plasma calcidiol levels below the
lower limit of normal (10 ng/ml). After exclusion of these
patients the mean value (± SEM) for plasma calcidiol is 16.2
1.2 ng/mi and the correlation between plasma calcidiol and
0.2
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Fig. 3). No correlation between calcium and sodium excretion
on free or Ca restricted diet was observed.
Vertebral mineral density was not correlated with fasting
calciuria but was positively correlated with plasma calcitriol
(Fig. 4). Vertebral mineral density was not correlated to hy-
droxyprolinuria nor to Gla protein.
Plasma calcitriol was negatively correlated to fasting calciuria
(Fig. 5) and positively to the calciuria increase after the calcium
load (an index of calcium absorption; Fig. 6). Plasma calcitriol
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Fig. 6. Correlation of calciuria increase after oral calcium load with
fasting plasma calcitriol in patients with dietary calcium-independent
hypercalciuria. y = 0.06 + 0.007x; r = 0.65; P < 0.01.
plasma calcitriol is still significant (P = 0.01, r = 0.57, least
squares method; P = 0.05, r = 0.5 Spearman rank coefficient).
Serum PTH was not correlated to plasma calcitriol nor to
fasting calciuria. Serum PTH was correlated to plasma Gla
protein with the least squares method, but not with the Spear-
man's test.
Discussion
Bone density in hypercalciuric calcium stone formers
Vertebral mineral density was significantly decreased in
calcium stone formers with hypercalciuria independent of cal-
Plasma P04, mmoliliter
Fig. 8. Correlation of plasma calcitriol with plasma phosphate in
patients with dietary calcium-independent hypercalciuria and normo-
phosphatemia. y = 169 — 1.OSx; r = 0.50; P < 0.01.
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Fig. S. Correlation of fasting calciuria with fasting plasma calcitriol in
patients with dietary-calcium independent hypercalciuria. y 0.77 —
0.005; r = —0.41; P < 0.05.
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Fig. 7. Correlation of plasma calciiriol with plasma calcidiol in pa-
tients with dietary calcium-independent hypercalciuria. y = 34 + 2.Sx;
r = 0.65; P < 0.01.
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cium intake (IH) but not in those with dietary hypercalciuria. In
patients with IH this density even reached the fracture thresh-
old which corresponded to 70% of the normal mean. In fact, one
patient in this group had a vertebral crush fracture.
Decrease in bone mineral density has already been reported
in calcium stone formers by other authors using different
techniques such as photonabsorptiometry of the distal radius
[18] or of the lumbar spine [19], radiological densitometry of the
proximal radial shaft [20], and in vivo neutron activation of the
trunk and upper thighs [21]. However, in most of these studies
insufficient data on the patients' calciuria and PTH levels were
given. In two studies decreased bone mineral density was
claimed to be present only in calcium stone formers with renal
hypercalciuria, but this pathophysiological entity was actually
proven by increased nephrogenic cAMP and/or increased PTH
levels only in the study of Lawoyin et al [221 but not in that of
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Lindergard et al [23]. In our study only one patient of the 24
with IH could be considered to have renal hypercalciuria. His
vertebral mineral density was the third lowest of all the pa-
tients. Patients with absorptive hypercalciuria type I had a
decreased mineral density of 71 4%, that is, comparable to
patients with undetermined fasting hypercalciuria (68 5%) in
spite of the fact that they had normal fasting calciuria.
Justification for the class jfication of hypercalciuria according
to dietary calcium dependency, but not for further
subclassification
The fact that the single patient with renal hypercalciuria had
the third lowest VMD is in agreement with the data of Lawoyin
et a! and the primary pathophysiological mechanism proposed
by Pak et al, namely the primary renal leak of calcium.
However, its prevalence is very low: 1 out of 42 hypercalciuric
calcium stone formers, that is, 2.4%. This makes the clinical
relevance of this classification questionable.
The distinction between absorptive hypercalciuria type I and
Undetermined hypercalciuria according to the level of fasting
calciuria does not appear to be justified by our data. Against
making this distinction is the absence of difference in hydroxy-
prolinuria, in the vertebral mineral density and in the calciuria
increase after oral calcium load, suggesting comparable absorp-
tion of calcium.
Since Muldowney, Freaney and Moloney [3] and Goldfarb [4]
have shown that high sodium intake could increase fasting
calciuria, it is interesting to note that this phenomenon could
not explain the fasting hypercalciuria of the undetermined
hypercalciuria subgroup, since the natriuresis of the previous
day was not significantly different in the fasting hypercalciuric
group than in the subgroup with absorptive hypercalciuria or in
the controls. The absence of higher natriuresis in fasting hyper-
calciuria exists whether the calciuria is expressed per mmol of
creatininuria or in absolute value per 24 hours. Thus it cannot
be argued that the higher meat intake of calcium stone formers
has led to higher creatinine excretion, which could explain that
when the natriuresis is reported as a ratio on creatinine, it
would be falsely diluted and therefore a higher sodium excre-
tion would be masked in these patients.
Since Jaeger et a! [24] have pointed out a high prevalence of
obesity (40%) in patients with so-called idiopathic hypercalci-
uria and that the associated hyperinsulinism may be responsible
of hypercalciuria, it is interesting to note that our population
with dietary calcium independent hypercalciuria had compara-
ble body weight to that of the controls, making it unlikely that
hyperinsulinism is the main explanation for hypercalciuria.
Finally, it should be pointed out that only two patients had
hypophosphatemia and could therefore enter the subgroup of
absorptive hypercalciuria type III of Pak et al [2].
Therefore, we think with many authors [1, 5, 6] that the most
clinically relevant distinction in hypercalciuric calcium stone
formers is that of dietary hypercalciuria from the dietary
calcium-independent hypercalciuria, that is, the usually called
idiopathic hypercalciuria. This simple classification does not
exclude, however, the role of other dietary factors such as salt,
carbohydrates and, as it will be discussed later, animal protein
intake.
Should the presence of medullary sponge kidney (MSK) be
considered in the classification of hypercalciuria? This is a
controversial issue. As a matter of fact, the presence of MSK is
a well recognized risk factor of calcium lithiasis and should not
point to patients having this abnormality as idiopathic calcium
stone formers [10, 24]. However, the link between MSK and
idiopathic (dietary calcium-independent) hypercalciuria, espe-
cially the renal hypercalciuria subtype, is not established for the
following reasons: (1) hypercalciuria is inconstant in patients
with MSK and its prevalence in these patients is not higher than
in those without MSK (44% vs. 36% in the series of Parks et a!
[10]); (2) there is no agreement in the diagnosis criteria of MSK
since authors like Parks et al [10] demand distinct radial linear
striation or cystic collections of contrast medium in at least half
of the papillae of both kidneys, whereas Jaeger et a! [241 and
Yendt, Jarzylo and Cohanim [25] consider that MSK is present
when only one or two papillae are involved. (3) In contradiction
with the presumed link between MSK and primary renal leak of
calcium, the increase of serum PTH levels compatible with this
diagnosis was quite inconstant since it was present in only 2 out
of 11 patients of Yendt et al [251 in none of the six patients of
Jaeger eta! [24], and in 7 out of the 10 patients of Maschio et al
[26] and in 3 of the 15 patients of O'Neill, Breslau and Pak [27].
Our three patients with MSK had dietary hypercalciuria in one
case, dietary calcium independent hypercalciuria in two cases,
of which only one had an actual renal hypercalciuria. It seems
reasonable to discuss the pathophysiology of dietary calcium
independent, that is, idiopathic, hypercalciuria at the exclusion
of its relation to MSK.
Evidence for bone hyperresorption in dietary calcium-
independent hypercalciuria (idiopathic hypercalciuria)
Besides decreased vertebral mineral density, our patients
with idiopathic hypercalciuria were characterized by a fasting
calciuria greater than in the controls and in the patients with
dietary hypercalciuria, and by normal plasma concentrations of
PTH, except in the single patient with renal hypercalciuria.
Their fasting calciuria was correlated to fasting hydroxypro-
linuria, suggesting that this hypercalciuria was linked to bone
hyperresorption since hydroxyprolinuria is a known marker of
bone resorption. Furthermore, fasting hydroxyprolinuria was
higher in our IH patients than in controls. This has already been
reported by others [9, 28, 291. This abnormality together with
results of calcium kinetics studies [30, 31] has led to the
suggestion of increased bone resorption. These data also agree
with the bone histological studies of Bordier, Ryckewaert and
Gueris [321, who found increased osteoclastic surfaces accom-
panied by decreased osteoblastic surfaces in idiopathic hyper-
calciuric patients with normal or low plasma concentrations of
PTH and phosphate, and of Steiniche et al [33] who found an
increase in the resorption surfaces in 33 patients with idiopathic
hypercalciuria, hypophosphatemia and normal PTH. In con-
trast to these reports, Malluche et al [34] found normal or
decreased bone resorption associated with decreased bone
formation and mineralization in patients with idiopathic hyper-
calciuria, but this latter was exclusively of the absorptive type
I without fasting hypercalciuria. The fasting hypercalciuria of
our patients could contributed to the decreased bone mass,
although the negative correlation between fasting calciuria and
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vertebral mineral density did not reach the level of significance
(P 0.07 only).
This increased bone resorption is not mediated by PTH since
PTH levels were normal except in the single patient mentioned
above. Increased plasma calcitriol concentration could theoret-
ically contribute to fasting hypercalciuria because in fasting
normal individuals on a calcium restricted diet, low dose of
calcitriol has been proven to increase calciuria and to induce a
negative calcium balance [35]. However this is not the case in
our patients with idiopathic hypercalciuria, since their elevated
plasma calcitriol was positively correlated to their vertebral
mineral density and negatively correlated to fasting hypercalci-
uria. On the contrary, high plasma calcitriol in idiopathic
hypercalciuria seems to have a protective effect for the skeleton
by increasing the calcium absorption during the day; plasma
calcitriol was correlated to the calciuria increase after a calcium
load, that reflects calcium absorption. During the night, a
primary bone hyperresorption would induce a primary release
of skeletal calcium which may suppress calcitriol synthesis,
explaining the negative correlation between fasting plasma
calcitriol and fasting calciuria.
Although Broadus et al [36] and Adams et al [37] have shown
that administration of calcitriol to healthy individuals could
induce a fasting hypercalciuria due to increased intestinal
absorption of calcium, the fasting hypercalciuria of our patients
can not be explained by increased plasma calcitriol levels
inducing a prolonged calcium absorption since: (a) there was no
significant difference between undetermined hypercalciuria and
absorptive hypercalciuria type I regarding the plasma calcitriol
levels and the increase of calciuria after the oral calcium load;
(b) a negative correlation, but not a positive one, was observed
between plasma calcitriol and fasting calciuria. Even if fasting
calciuria was not measured in our patients after administration
of cellulose phosphate to cancel any question of intestinal
calcium hyperabsorption, the fasting calciuria of our patients
appears to originate mainly from bone resorption, since fasting
calciuria was correlated to fasting hydroxyprolinuria in IH (RH
patient being excluded).
Mechanisms of bone hyperresorption in idiopathic
hypercalciuria
Two kinds of explanation may be proposed. The first one is
an immunological one involving the monocyte. Pacific et a! [29]
have recently found an increased production of interleukin I by
peripheral blood monocytes, associated with increased hydroxy-
prolinuria in calcium stone formers with fasting hypercalciuria.
Interleukin I may indirectly induce bone resorption by stimu-
lating prostaglandin bone resorption [38, 39]. This latter is
known to be increased in idiopathic hypercalciuria and reduced
by prostaglandin synthetase inhibition [40].
The second explanation is a nutritional one. High protein
intake has been shown to favor osteoporosis [411 and hypercal-
ciuria [24, 42—44], possibly by inducing a subtle metabolic
acidosis [1, 451 as it increases the amount of amino acid sulfur
oxidized to sulfate. This acidosis will release calcium salts from
bone since these salts are used to buffer H ions [45, 46]. It
leads to an increase of the calcium filtered load and therefore to
hypercalciuria, since tubular reabsorption of calcium is simul-
taneously decreased by a direct effect of acidosis as well as by
the fact that sulfate in the tubular lumen is poorly reabsorbed
and complexes calcium [1, 47]. In our patients with idiopathic
hypercalciuria, urea excretion was significantly higher on a
calcium restricted diet than in the controls, suggesting that their
protein intake of non-dairy origin was greater. High protein
catabolism could not explain this higher urea excretion because
the patients' condition was excellent. Furthermore, the corre-
lations between urea and calcium excretions were dramatic in
this group of patients. Comparative to controls, the slope of the
regression of fasting calciuria with urea excretion on free diet
was five times steeper in the patients with idiopathic hypercal-
ciuria, suggesting an increased sensitivity to the hypercalciuric
action of dietary protein in this group. Such an increased
sensitivity has been previously reported by Goldfard [4] in
calcium stone formers regardless of their calciuria type. Finally
urea excretion on calcium restricted diet was correlated to
fasting hydroxyprolinuria and fasting calciuria whereas fasting
calciuria correlated with fasting hydroxyprolinuria. Such corre-
lations were not found in controls, suggesting that the patients
with idiopathic hypercalciuria may be more sensitive to the
resorptive effect of high protein intake that the controls. Since
on calcium restricted diet the dairy products were excluded, the
higher urea excretion observed on this diet in patients with
idiopathic hypercalciuria suggests that their protein intake of
non-dairy origin was higher. This high intake of animal protein
actually increases calciuria simultaneously with hydroxypro-
linuria and decreases urinary pH in calcium stone formers as
this has been well demonstrated by FellstrOm et al [48]. The role
of the acidosis induced by protein excess in the hypercalciuria
of IH patients, however, is not predominant since it has been
shown that at any given rate of renal net acid excretion, the
calcium excretion is higher among patients with IH than in
controls [49].
Disorder in the control of calcitriol synthesis in idiopathic
hypercalciuria
In our patients with idiopathic hypercalciuria, fasting plasma
calcitriol after four days of calcium restricted diet have been
found elevated comparatively to controls. The mean value is 69
5 pg/ml, a value very close to that found by Broadus et al [5,
50] (76 10 pg/ml) in the same dietary conditions in his calcium
stone formers with dietary independent hypercalciuria and
increased calcium absorption after an oral calcium load. In-
creased plasma calcitriol level have also been reported in
hypercalciuric Ca stone formers by other authors [51—54] with
the exception of Coe et a! [55], even with a very restricted
calcium diet (<3.5 mmol/70 kg). These increased plasma levels
of calcitriol have been proved to be in relation with increased
synthesis not with decreased metabolic clearance [56].
What is remarkable in our patients is the negative correlation
between plasma calcitriol and plasma phosphate although this
latter remains in the normal range. This observation has been
checked after exclusion of two patients with low plasma phos-
phate levels. Up to now this negative correlation between
calcitriol and phosphate had been observed only in calcium
stone formers with hypophosphatemia probably because of a
primary renal leak of phosphate (absorptive hypercalciuria type
III of Pak et a!) [51, 52, 54—57]. This negative correlation is in
accordance with the animal data showing that hypophos-
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phatemia stimulates 25 (OH) vitamin D1 hydroxylase by a
growth hormone-dependent mechanism [58]. However, Portale
et al [59] have reported that oral intake of phosphorus could
inversely influence the production of calcitriol in humans in the
absence of hypophosphatemia. Lower intakes of P04 are very
unlikely in our patients since their P04 excretion on Ca re-
stricted diet was higher than in controls in parallel with higher
urea excretion, suggesting a higher intake of protein of non-
dairy origin. Therefore the higher levels of calcitriol in our
patients can not be explained by lower intakes of P04. A
particular sensitivity of the 25 (OH) vitamin D1 hydroxylase to
plasma phosphate may therefore be postulated in our patients.
This hypothesis is not supported by Insogna et al [60] who
found that idiopathic hypercalciuric patients have a blunted
response to their plasma calcitriol levels to the decrease of
phosphate intake comparatively to normals. A negative corre-
lation between plasma P04 and plasma calcitriol has also been
reported in a Beduin tribe having members with asymptomatic
hypercalciuria and only very mild hypophosphatemia (—1 SD of
the mean of normal), besides members with hypophosphatemic
rickets with hypercalciuria or members without any phospho-
calcic abnormalities [611. Since, with the exception of two
patients all our patients with IH had normal plasma P04 and
normal fasting urinary phosphate it is difficult to postulate that
they had a mild form of phosphate renal leak.
The positive correlation between plasma calcitriol and
plasma calcidiol is also unusual, since besides urolithiasis such
a correlation has up to now only been reported in kidney
transplant patients with renal failure [62], in elderly patients
with primary hyperparathyroidism, mild renal insufficiency and
vitamin D depletion [63], as well as in elderly normocalcemic
subjects without primary hyperparathyroidism but with vitamin
D depletion [641. After exclusion of vitamin D depleted pa-
tients, this correlation holds true, which excludes vitamin D
depletion as the primary explanation for this particular relation-
ship between plasma calcidiol and plasma calcitriol in most of
our patients. In normal vitamin D repleted man Bell et al [65]
have shown that an increase in plasma 25 (OH) D induces a
decrease in calcitriol production. In calcium stone formers,
Varghese et al [661 have shown that, on the contrary, the
increase of plasma 25 (OH) D (induced by ultraviolet B radia-
tion) was associated with an increase in plasma calcitriol levels.
Thus vitamin D metabolism is characterized in idiopathic
hypercalciuria by a disordered control of calcitriol synthesis.
The nature and the site of this disturbed metabolism is un-
known. Two explanations have been proposed by Lemann and
Worcester [671: activation of the renal 25 (OH) vitamin D1
hydroxylase by an increased sensitivity of the enzyme to PTH
or an occult extrarenal calcitriol synthesis in a granulomatous
disorder like sarcoidosis [68]. This latter hypothesis may be put
in relation with the abnormality of the monocytes observed in
calcium stone formers with fasting hypercalciuria which have
been proved to excessively secrete interleukin I [29]. As a
matter of fact, interleukin I stimulates prostaglandin synthesis
and prostaglandins have been proved to stimulate both bone
resorption [40] and calcitriol synthesis [691. Thus the two
apparently contradictory phenomena that we have found in our
patients with idiopathic hypercalciuria, namely the increased
bone resorption leading to reduction of bone density and the
protective effect of high plasma calcitriol levels, could be
explained by abnormal monocytes.
Since in our patients we have a negative correlation between
plasma calcitriol and plasma phosphate and a positive one
between plasma calcitriol and plasma calcidiol, in spite of
normal plasma phosphate and low or normal plasma calcidiol,
but no correlation between plasma calcitriol and plasma PTH,
we speculate that they have a hypersensitivity of their 25 (OH)
vitamin D1 hydroxylase to plasma P04, making calcitriol
synthesis dependent on normal levels of 25 (OH) vitamin D.
Explanation of the normal vertebral mineral density in dietary
hypercalciuria
The absence of decreased vertebral mineral density in spite
of hypercalciuria may be explained by two nutritional factors: a
higher intake of calcium and intake of non-dairy proteins lower
than in patients with dietary calcium-independent hypercalci-
uria (IH). The higher calcium intake in this group is suggested
by the normalization of calciuria when the patient has de-
creased his calcium intake. The lower intake of non-dairy
protein in this group is suggested by the fact that urea excretion
on calcium restricted diet (without dairy product) is lower than
in IH patients. Furthermore, as in IH patients, the increased
plasma concentration of calcitriol, may play also a protective
effect by increasing calcium absorption. A potential hyperre-
sorption due to increased levels of calcitriol is unlikely because
of the normal hydroxyproline excretion.
Therapeutical implications
The fact that vertebral mineral density is decreased in cal-
cium stone formers with dietary calcium-independent hypercal-
ciuria but not in patients with dietary hypercalciuria militates
against the formerly proposed restriction of dairy products in all
calcium stone formers, a measure which is still very popular
although its actual efficacy for prevention of lithiasis recurrence
has never been proven [70]. As a matter of fact, this measure
may have a deleterious effect on the bone of the patients by
reducing their calcium intake, as it has been recently shown in
calcium stone formers by Fuss et al [711, distal radius bone
mineral content being significantly lower in those maintained on
a low calcium diet for four years than in those maintained on a
free diet. Therefore for all patients we recommend a normal
calcium diet of 800 to 1000 mg and no dairy product restriction.
Another reason for not restricting calcium intake is that this
restriction increases oxaluria, which results in IH patients
having an increase of the index of Robertson which evaluates
the probability of being a stone former [72]. Therefore the only
safe dietary measures advisable to reduce hypercalciuria are
lower intakes of non-dairy protein, salt and excessive carbohy-
drates. When hypercalciuria persists in spite of these dietary
measures, thiazides may be added since they reduce calciuria
and have been proven independently to be capable of prevent-
ing both bone loss [73—751 and lithiasis recurrence [76, 77].
Prospective studies comparing thiazide therapy to placebo will
be necessary to demonstrate their skeleton protective effect in
calcium stone formers with idiopathic hypercalciuria.
Conclusions
(1.) Vertebral mineral density is decreased in calcium stone
formers with dietary calcium independent hypercalciuria (IH)
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but not in patients with dietary hypercalciuria. The distinction
of these two groups of hypercalciuric patients is therefore
clinically relevant.
(2.) The further distinction within IH of absorptive hypercal-
ciuria type 1(8 patients) from renal hypercalciuria (1 patient) is
clinically more questionable, since 15 patients with fasting
hypercalciuria and normal PTH remained unclassified, and
because vertebral mineral density and biochemical parameters
(at the exception of those taken for sub-classification) were
comparable in absorptive hypercalciuria type I and undeter-
mined fasting hypercalciuria.(3.) A primary bone hyperresorption is the most likely
explanation of most dietary calcium independent hypercalci-
uria, since (1) fasting hypercalciuria was correlated to fasting
hydroxyprolinuria; (2) fasting hydroxyprolinuria was higher in
IH than in controls; and (3) plasma concentrations of PTH are
low normal, with exception of one case with renal hypercalci-
uria and medullary sponge kidney.
(4.) Bone resorption in IH was associated with and may be
enhanced by a high protein intake of non-dairy origin, since
fasting hypercalciuria and hydroxyprolinuria are correlated to
urea excretion on a diet excluding dairy products.
(5.) Bone resorption in IH seems to be suppressed by high
plasma calcitriol favoring calcium absorption, since plasma
calcitriol is negatively correlated to fasting calciuria and posi-
tively correlated to vertebral mineral density and to the calci-
uria increase induced by a calcium load.
(6.) Calcitriol synthesis is disturbed in IH since plasma levels
of calcitriol are elevated, whereas the plasma levels of calcidiol
are normal, and plasma calcitriol is positively correlated to
plasma calcidiol. Furthermore, in spite of normophosphatemia,
plasma calcitriol is negatively correlated to plasma P04, sug-
gesting a hypersensitivity of the 25 (OH) vitamin D1 hydroxy-
lase to plasma P04.
(7.) From a therapeutical point of view, these data suggest
that exclusion of dairy products in hypercalciuric patients may
be deleterious for their skeleton and that restriction of protein
of non-dairy origin (especially meat) should be advised.
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